tDCS Effect on Psychotic Symptoms in Dementia With Lewy Bodies (DLB), and Impacts on Caregiver Burden
Recruiting
N/A
Interventional Study
Lewy Body Dementia
Lewy Body Dementia With Behavioral Disturbance
Burden, Caregiver
Lewy Body Disease
Dementia With Lewy Bodies
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 60 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Association de Recherche Bibliographique pour les Neurosciences · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this pilot prospective study is to evaluate the effect of tDCS on psychotic-like symptoms in patients with Lewy Body Dementia (LBD). The main questions it aims to answer are:
* What is the effect of tDCS on neuropsychiatric symptoms, especially psychotic-like symptoms?
* What is the impact of tDCS on caregiver burden?
Researchers will compare active tDCS (2mA stimulation, anode on th…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or Female, aged over 60,
* Diagnosed with a neurodegenerative pathology of the DLB type, at a moderate stage, according to the McKeith and al. (2017) criteria
* No change in antiparkinsonian or psychotropic medications, or cholinesterase inhibitors, for a period of one mo…
Contacts